Investor profile
Indaco Venture Partners has backed 13 European tech companies across 16 funding rounds between 2018 and 2026, joining rounds totalling €387M. Most active in Software and Healthtech. Data as of 6 Aug 2026.
Also recorded as: Indaco Venture Partners SGR · Indaco Ventures · Indaco Ventures Partners · Indaco Ventures Partners SGR
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| D-Orbit | Italy | 1 | €100M |
| Newcleo | UK | 1 | €72M |
| InnovHeart | Italy | 1 | €49M |
| Talent Garden | Italy | 1 | €44M |
| CamGraPhic | UK | 1 |
| Company | Stage | Amount | Date |
|---|---|---|---|
| D-Orbit | Series C | €100M | 2024-01 |
| Newcleo | Other | €72M | 2026-02 |
| InnovHeart | Series C | €49M | 2022-01 |
| Talent Garden |
| €25M |
| Sibylla Biotech | Italy | 1 | €23M |
| Easyrain | Italy | 4 | €19M |
| Valo Therapeutics | Finland | 1 | €19M |
| Newronika | Italy | 1 | €14M |
| Cortilia | Italy | 1 | €8.5M |
| Sweetguest | Italy | 1 | €8.0M |
| CYSEC | Switzerland | 1 | €3.9M |
| Cellply | Italy | 1 | €2.0M |
| €44M |
| 2019-01 |
| CamGraPhic | Series A | €25M | 2025-03 |
| Sibylla Biotech | Series A | €23M | 2022-10 |
| Valo Therapeutics | Other | €19M | 2025-03 |
| Newronika | Series B | €14M | 2025-02 |
| Cortilia | Series B | €8.5M | 2019-10 |
| Sweetguest | Series B | €8.0M | 2019-04 |
